(Q39314896)

10 September 2017

The essential role of glucagon in the pathogenesis of diabetes mellitus (English)

2 references

10 September 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A46337

6 April 2022

0 references

1 reference

R. H. Unger

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A46337

6 April 2022

L. Orci

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A46337

6 April 2022

language of work or name

English

0 references

publication date

1 January 1975

1 reference

10 September 2017

4 January 1975

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=46337

full work available at URL

6 April 2022

https://api.elsevier.com/content/article/PII:S0140673675923752?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(75)92375-2

https://api.elsevier.com/content/article/PII:S0140673675923752?httpAccept=text/plain

6 April 2022

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(75)92375-2

6 April 2022

1 reference

10 September 2017

1

1 reference

10 September 2017

14-16

1 reference

10 September 2017

7897

1 reference

Diabetes mellitus nach Pankreasexstirpation

10 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2992375-2

7 January 2021

Pancreatic Glucagon Secretion in Normal and Diabetic Subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2992375-2

7 January 2021

Studies of pancreatic alpha cell function in normal and diabetic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2992375-2

7 January 2021

Abnormal alpha-cell function in diabetes. Response to carbohydrate and protein ingestion.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2992375-2

7 January 2021

Abnormal alpha cell function in diabetics response to insulin.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2992375-2

7 January 2021

Abnormalities of glucagon metabolism in untreated diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2992375-2

7 January 2021

Abnormal Secretion of Insulin and Glucagon by the In Vitro Perfused Pancreas of the Genetically Diabetic Chinese Hamster

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2992375-2

7 January 2021

Action of streptozotocin on insulin and glucagon responses of rat islets.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2992375-2

7 January 2021

Hepatic Autophagy in Uncontrolled Experimental Diabetes and Its Relationships to Insulin and Glucagon

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2992375-2

7 January 2021

Hyperglucagonaemia after burns

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2992375-2

7 January 2021

Serum glucagon and insulin levels and their relationship to blood glucose values in patients with acute myocardial infarction and acute coronary insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2992375-2

7 January 2021

Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth Hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2992375-2

7 January 2021

Effects of growth-hormone release-inhibiting hormone on circulating glucagon, insulin, and growth hormone in normal, diabetic, acromegalic, and hypopituitary patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2992375-2

7 January 2021

Somatostatin: Hypothalamic Inhibitor of the Endocrine Pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2992375-2

7 January 2021

Inhibition of insulin secretion by somatostatin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2992375-2

7 January 2021

Somatostatin-induced changes in insulin and glucagon secretion in normal and diabetic dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2992375-2

7 January 2021

Glucagon control of fasting glucose in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2992375-2

7 January 2021

Effects of glucagon on lipolysis and ketogenesis in normal and diabetic men

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2992375-2

7 January 2021

Influence of glucagon and 3', 5'-AMP on insulin responsiveness of the perfused rat liver

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2992375-2

7 January 2021

Antagonism Between the Effects of Insulin and Glucagon on the Isolated Liver

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2992375-2

7 January 2021

Effects of somatostatin on plasma glucose and glucagon levels in human diabetes mellitus. Pathophysiologic and therapeutic implications.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2992375-2

7 January 2021

The physiological significance of the secretion of endogenous insulin into the portal circulation. III. Evidence for a direct immediate effect of insulin on the balance of glucose across the liver

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2992375-2

7 January 2021

Control of Pancreatic Glucagon Secretion by Glucose

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2992375-2

7 January 2021

Journal of Clinical Investigation

9

50

Muller

1971

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(75)92375-2

Journal of Clinical Investigation

6 April 2022

28

53

28

Goodner

1974

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(75)92375-2

6 April 2022

Identifiers

1 reference

10 September 2017

1 reference